RNA — Avidity Biosciences Share News
0.000.00%
Last trade - 00:00- $11.27bn
- $9.40bn
- $10.90m
Novartis finds neat M&A cure for growth pains
Novartis shares slip, Avidity soars after $12 billion biotech deal
Avidity Biosciences eyes record high after Novartis' $12 bln deal to buy co
Swiss stocks - Factors to watch on October 27
Press Digest: Wall Street Journal - October 27
Brief: Avidity Biosciences Says Spinco To Be Led By Kathleen Gallagher As Ceo
Novartis to acquire Avidity Biosciences for about $12 billion (updated)
Novartis to acquire Avidity Biosciences for $12 billion
Brief: Novartis AG Says Acquisition Of Avidity Valued At $12 Billion
Novartis nears deal to acquire Avidity Biosciences for over $70 per share, Bloomberg News reports (updated)
Novartis nears $70-plus per share deal to acquire Avidity Biosciences, Bloomberg News reports
Brief: Novartis Said To Near $70-Per-Share-Plus Deal For Avidity-Bloomberg News
U.S. STOCKS ON THE MOVE-Keurig Dr Pepper, Ardelyx, Vertiv
U.S. STOCKS ON THE MOVE-Broadcom, JPMorgan, Enpro
Avidity rises on plans to submit muscle wasting drug application to US FDA
Brief: Avidity Biosciences Announces Positive Pre-BLA Meeting With US FDA For del-zota In DMD44
Brief: Avidity Biosciences Files For Offering Of 15 Million Shares Of Common Stock - SEC Filing
U.S. STOCKS ON THE MOVE-Vaccine makers, NextDecade, Alaska Air Group
U.S. STOCKS ON THE MOVE-Warner Bros Discovery, Cocrystal Pharma, Prenetics Global